LO Francis, the Chief People Officer at Adaptive Biotechnologies Corp, has made notable stock transactions recently, as detailed in an SEC filing. The filing reveals that Francis acquired and disposed of significant amounts of common stock on October 1, 2026. This activity is important as it reflects the management's confidence and potential strategy regarding the company's stock.
Adaptive Biotechnologies Corp, based in Seattle, operates in the life sciences sector, specifically focusing on biological products. The company is traded under the ticker symbol ADPT and is registered with the SEC under the CIK number 0001478320. Recent filings indicate ongoing activity, including multiple transactions reported in the last few months.
According to the filing dated October 5, 2026, Francis executed several transactions on October 1, 2026. The details include:
"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."
In total, Francis acquired 8,038 shares at $8.46 each, 9,377 shares at $3.99, and 9,377 shares at $8.12. Additionally, he disposed of 8,094 shares at $27.52 and 18,698 shares at $28.61. Following these transactions, Francis holds a total of 220,867 shares of common stock.
This filing may affect various stakeholders, including investors and analysts monitoring Adaptive Biotechnologies' performance and strategy. The life sciences sector, particularly companies involved in biological products, will be observing how these transactions influence market perceptions and investor confidence.
As for what’s next, the filing does not specify any upcoming events or additional filings related to these transactions.